摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

头孢丙烯杂质7 | 111900-24-4

中文名称
头孢丙烯杂质7
中文别名
——
英文名称
(6R,7R)-7-[2-amino-2-(4-hydroxyphenyl)acetamido]-3-[(Z)-propenyl]-3-cephem-4-carboxylic acid monohydrate
英文别名
Cefzil;(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate
头孢丙烯杂质7化学式
CAS
111900-24-4
化学式
C18H19N3O5S*H2O
mdl
——
分子量
407.447
InChiKey
ALYUMNAHLSSTOU-CIRGZYLNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.12
  • 重原子数:
    28
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    159
  • 氢给体数:
    5
  • 氢受体数:
    8

ADMET

毒理性
  • 在妊娠和哺乳期间的影响
◉ 母乳喂养期间使用总结:有限的信息表明,头孢丙烯在乳汁中产生的水平较低,预计不会对哺乳婴儿造成不良影响。偶尔有报道称,使用头孢菌素会破坏婴儿的胃肠道菌群,导致腹泻或鹅口疮,但这些影响尚未得到充分评估。头孢丙烯在哺乳期母亲中是可以接受的。 ◉ 对哺乳婴儿的影响:截至修订日期,没有找到相关的已发布信息。 ◉ 对泌乳和母乳的影响:截至修订日期,没有找到相关的已发布信息。
◉ Summary of Use during Lactation:Limited information indicates that cefprozil produces low levels in milk that are not expected to cause adverse effects in breastfed infants. Occasionally disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush have been reported with cephalosporins, but these effects have not been adequately evaluated. Cefprozil is acceptable in nursing mothers. ◉ Effects in Breastfed Infants:Relevant published information was not found as of the revision date. ◉ Effects on Lactation and Breastmilk:Relevant published information was not found as of the revision date.
来源:Drugs and Lactation Database (LactMed)

SDS

SDS:36b844a8909b5d04f8ff8cc4ec266db2
查看

反应信息

  • 作为产物:
    描述:
    头孢丙烯(E)-异构体乙酸乙酯 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 1.0h, 生成 头孢丙烯杂质7
    参考文献:
    名称:
    Process for preparation of 7-[α-amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
    摘要:
    一种制备高纯度、基本无杂质的7-[D-α-氨基-α-(4-羟基苯基)乙酰氨基]-3-(1-丙烯-1-基)-3-头孢烯-4-羧酸,即式(I)的方法,包括选择试剂的加入顺序和温度,制备混合酸酐,并将其与保护的7-APCA缩合;随后进行水解、分离和纯化,得到单水合物形式的式(I)的头孢唑酯。
    公开号:
    US07427692B2
点击查看最新优质反应信息

文献信息

  • Process for preparation of 7-[alpha-amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
    申请人:Tyagi Dutt Om
    公开号:US20050113570A1
    公开(公告)日:2005-05-26
    A process for preparation of 7-[D-α-amino-α-(4-hydroxyphenyl)acetamido]-3-(1-propen-1-yl)-3-cephem-4-carboxylic acid viz. Cefprozil of formula (I) igh purity, substantially free of impurities, which comprises preparation of mixed acid anhydride by selecting the sequence and temperature of addition of the reagents and its subsequent condensation with a protected 7-APCA; followed by hydrolysis, isolation and purification to give Cefprozil of formula (I) in the form of a monohydrate.
    一种制备高纯度、基本无杂质的7-[D-α-氨基-α-(4-羟基苯基)乙酰氨基]-3-(1-丙烯-1-基)-3-头孢烯-4-羧酸,即化学式(I)的方法,包括通过选择试剂的加入顺序和温度制备混合酸酐,并将其与保护的7-APCA缩合;随后进行水解、分离和纯化,以得到一水合物形式的化学式(I)的头孢唑酯。
  • Process for preparation of 7-[a-amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
    申请人:Tyagi Dutt Om
    公开号:US20060149096A1
    公开(公告)日:2006-07-06
    A process for preparation of 7-[D-α-amino-α-(4-hydroxyphenyl)acetamido]-3-(1-propen-1-yl)-3-cepham-4-carboxylic acid viz. Cefprozil of formula (I) igh purity, substantially free of impurities, which comprises preparation of mixed acid anhydride by selecting the sequence and temperature of addition of the reagents and its subsequent condensation with a protected 7-APCA; followed by hydrolysis, isolation and purification to give Cefprozil of formula (I) in the form of a monohydrate.
    一种制备高纯度、基本无杂质的7-[D-α-氨基-α-(4-羟基苯基)乙酰氨基]-3-(1-丙烯-1-基)-3-头孢-4-羧酸(式(I))的方法,包括通过选择试剂的加入顺序和温度制备混合酸酐,然后与保护的7-APCA缩合;随后进行水解、分离和纯化,得到一水合物形式的式(I)的Cefprozil。
  • Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
    申请人:Lupin Ltd.
    公开号:US07230097B2
    公开(公告)日:2007-06-12
    A process for preparation of 7-[D-α-amino-α-(4-hydroxyphenyl)acetamido]-3-(1-propen-1-yl)-3-cephem-4-carboxylic acid viz. Cefprozil of formula (I) in high purity, substantially free of impurities, which comprises preparation of mixed acid anhydride by selecting the sequence and temperature of addition of the reagents and its subsequent condensation with a protected 7-APCA; followed by hydrolysis, isolation and purification to give Cefprozil of formula (I) in the form of a monohydrate.
    一种制备高纯度、基本无杂质的7-[D-α-氨基-α-(4-羟基苯基)乙酰氨基]-3-(1-丙烯-1-基)-3-头孢烯-4-羧酸,即公式(I)的头孢普罗酯的方法,包括通过选择试剂加入的顺序和温度制备混合酸酐,并将其与保护的7-APCA缩合;随后进行水解、分离和纯化,得到以单水合物形式存在的公式(I)的头孢普罗酯。
  • NOVEL PROCESS FOR PREPARATION OF CEFPROZIL INTERMEDIATE
    申请人:PARTHASARADHI REDDY Bandi
    公开号:US20090048460A1
    公开(公告)日:2009-02-19
    The present invention relates to a process for preparing a key intermediate of cefprozil and use of this intermediate in the preparation of cefprozil thereby avoiding impurity-causing self-acylation. [R-(Z)]-[4-hydroxy-α-[(3-methoxy-1-methyl-3-oxo-1-propenyl)amino]] benzeneacetic acid, mono potassium salt is reacted with ethyl chloroformate to obtain mixed anhydride which is then silylated with N,O-bis(trimethylsilyl)acetamide. The silylated compound obtained is reacted with [7-trimethylsilylamino-3-(Z/E-propen-1-yl)-3-cephem-4-carboxylic acid]trimethylsilyl ester and deprotected with aqueous hydrochloric acid to give cefprozil.
    本发明涉及一种制备头孢普罗酯的关键中间体的方法,以及利用该中间体在制备头孢普罗酯过程中避免产生杂质引起的自酰化。首先将[R-(Z)]-[4-羟基-α-[(3-甲氧基-1-甲基-3-酮基-1-丙烯基)氨基]]苯乙酸单钾盐与氯甲酸乙酯反应得到混合酸酐,然后用N,O-双(三甲基硅基)乙酰胺对其进行硅化反应。得到的硅化化合物与[7-三甲基硅氨基-3-(Z/E-丙烯-1-基)-3-头孢烯-4-羧酸]三甲基硅酯发生反应,并用水盐酸去保护,最终得到头孢普罗酯。
  • Novel Process For Preparation of Cefprozil Intermediate
    申请人:Parthasaradhi Reddy Bandi
    公开号:US20080281093A1
    公开(公告)日:2008-11-13
    The present invention relates to a process for preparing a key intermediate of cefprozil and use of this intermediate in the preparation of cefprozil thereby avoiding impurity-causing self-acylation. [R-(Z)]-[4-hydroxy-α-[(3-methoxy-1-methyl-3-oxo-1-propenyl)amino]]benzeneacetic acid, mono potassium salt is reacted with ethyl chloroformate to obtain mixed anhydride which is then silylated with N,O-bis(trimethylsilyl)acetamide. The silylated compound obtained is reacted with [7-trimethylsilylamino-3-(Z/E-propen-1-yl)-3-cephem-4-carboxylic acid]trimethylsilyl ester and deprotected with aqueous hydrochloric acid to give cefprozil.
    本发明涉及一种制备头孢普罗酯的关键中间体的方法,以及利用该中间体在制备头孢普罗酯过程中避免自酰化引起的杂质。将[R-(Z)]-[4-羟基-α-[(3-甲氧基-1-甲基-3-氧代-1-丙烯基)氨基]]苯乙酸单钾盐与氯甲酸乙酯反应,得到混合酐,然后用N,O-双(三甲基硅基)乙酰胺硅化。所得到的硅化合物与[7-三甲基硅氨基-3-(Z/E-丙烯基)-3-头孢烯-4-羧酸]三甲基硅酯反应,并用水盐酸脱保护,得到头孢普罗酯。
查看更多

同类化合物

(6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 顺式-4-(2,2-二甲氧基乙基)-3-邻苯二甲酰-2-氮杂环丁酮 顺式-1-(对甲苯基)-3-苄氧基-4-(对茴香基)-氮杂环丁烷-2-酮 青霉酰聚赖氨酸 青霉素钾 青霉素钠 青霉素酶液体 青霉素杂质C 青霉素G衍生物 青霉素G甲酯 青霉素G甲酯 青霉素G-D7 青霉素 V 钠 阿那白滞素 阿莫西林钠 阿莫西林三水合物 阿莫西林 阿立必利D5 阿度西林 铜(2+)酞菁-29,30-二负离子-2-(二甲氨基)乙醇(1:1:1) 钾(2S,5R,6R)-6-[[2-[(E)-3-氯丁-2-烯基]巯基乙酰基]氨基]-3,3-二甲基-7-氧代-4-硫杂-1-氮杂双环[3.2.0]庚烷-2-羧酸酯 钠(6S,7R)-3-(羟基甲基)-7-甲氧基-8-氧代-7-[(2-噻吩基乙酰基)氨基]-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸酯 酞氨西林 萘夫西林杂质 苯磺酸,2-[(2-羟基-1-萘基)偶氮]-5-甲基-,盐(2:1)钡 苯氧乙基青霉素钾 苯唑西林钠 苯唑西林杂质1 舒巴坦杂质19 舒他西林 脱乙酰基戊二酰 7-氨基头孢烷酸 脱乙酰基头孢噻肟 肟莫南 羰苄西林苯酯钠 美罗培南钠盐 美罗培南 美洛培南 缩酮氨苄青霉素 紫杉醇侧链2 硫霉素 硫霉素 硫酸氢3-{[(6R,7R)-7-{[(2E)-2-(2-氨基-1,3-噻唑-4-基)-2-(甲氧基亚氨基)乙酰基]氨基}-2-羧基-8-羰基-5-硫杂-1-氮杂二环[4.2.0]辛-2-烯-3-基]甲基}-1,3-噻唑-3-正离子 硫酸头孢噻利 硫酸头孢喹诺 盐酸巴氨西林 盐酸头孢唑兰 盐酸头孢吡肟 盐酸头孢他美酯 盐酸头孢他美 癸二酸与六氢-2H-氮杂卓-2-酮,1,6-己烷二胺和己二酸的聚合物